Skip to content

Climb Bio, Inc. CLYM Cash Paid For Leases Included In Operating Cash Outflows

Other financials

Income statement

See full
Operating income-$15.2M+33.9%
Net income-$13.7M+34.0%
EPS (diluted)-$0.20+35.5%

Balance sheet

See full
Cash & equivalents$8.4M-71.2%
Total debt$479.0K+1.1%
Total equity$148.1M-23.4%
Total assets$152.4M-24.1%

Cash flow

See full
Operating cash flow-$14.4M+6.8%
CapEx$109.0K
Free cash flow-$15.6M-183%

Valuation

See full
Market cap$724.95M+787%
Enterprise value$717.07M+1,247%

Returns & leverage

See full
Return on equity-30.9%-10.3pp
Debt / equity0.0×
Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept clym:CashPaidForLeasesIncludedInOperatingCashOutflows.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s cash paid for leases included in operating cash outflows.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Climb Bio, Inc.'s cash paid for leases included in operating cash outflows?
Climb Bio, Inc. (CLYM) reported cash paid for leases included in operating cash outflows of $73K in Q1 2026.
How has Climb Bio, Inc.'s cash paid for leases included in operating cash outflows changed year-over-year?
Climb Bio, Inc.'s cash paid for leases included in operating cash outflows increased by 5.8% year-over-year, from $69K to $73K.